mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.8 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.0097 |
0.8 |